A Clinical Trial to Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
Clinical trial NCT04072354 · COMPLETED
Trial details
- NCT number
- NCT04072354
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-17
- Primary completion
- 2023-05-12
- Enrollment
- 463
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.